CellCura ASA reported unaudited consolidated earnings results for the fourth quarter and year ended December 31, 2012. For the quarter, the company reported total operating income of NOK 103,000 against NOK 962,000 a year ago. Operating loss was NOK 6,340,000 against NOK 6,312,000 a year ago. Loss before tax was NOK 8,284,000 against NOK 8,533,000 a year ago. Loss was NOK 8,162,000 or NOK 0.20 per diluted share against NOK 8,386,000 or NOK 0.27 per diluted share a year ago. For the year, the company reported total operating income of NOK 2,866,000 against NOK 1,024,000 a year ago. Operating loss was NOK 32,655,000 against NOK 31,998,000 a year ago. Loss before tax was NOK 33,088,000 against NOK 34,752,000 a year ago. Loss was NOK 32,590,000 or NOK 0.82 per diluted share against NOK 34,216,000 or NOK 1.18 per diluted share a year ago. Net cash flow from operating activities was NOK 19,473,000 against NOK 18,853,000 a year ago.

CellCura ASA announced that the company has postponed its scheduled fourth quarter of 2012 results. The presentation was originally scheduled for 14 February 2013. The presentation will now be held on 27 February 2013.

CellCura ASA, Q4 2012 Earnings Call, Feb 27, 2013